Results 171 to 180 of about 22,014 (216)
Some of the next articles are maybe not open access.
Acetazolamide and Urolithiasis
Ophthalmology, 1981Abstract: Interviews were conducted with 515 individuals between the ages of 20 and 80 years to gather data on acetazolamide therapy and the occurrence of urolithiasis. One hundred forty-eight patients were treated with chronic oral acetazolamide therapy for one week to 348 months (mean 40.9 months).
Michael Kass +2 more
exaly +3 more sources
Effects of Acetazolamide on Choroidal Blood Flow
Stroke, 1998 Background and Purpose —The acetazolamide provocation test is commonly used to study cerebrovascular vasomotor reactivity.
Oliver Findl +2 more
exaly +2 more sources
Dissociation of Vasoreactivity to Acetazolamide and Hypercapnia
Stroke, 1996 Background and Purpose The aim of this study was to compare the effect of vasodilative stimuli for the measurement of cerebrovascular reactivity obtained by acetazolamide and hypercapnia in patients with chronic occlusive major ...
Ken Kazumata +2 more
exaly +2 more sources
Evaluation of the Acetazolamide Test
Stroke, 1995 Background and Purpose We evaluated the potential usefulness of the acetazolamide test by investigating whether acetazolamide vasoreactivity reflected the change in resting cerebral blood volume caused by compensatory ...
Hajime Arai +3 more
exaly +2 more sources
Hemodialyzability of Acetazolamide
Southern Medical Journal, 1980Because the dialyzability of acetazolamide is not known, we undertook a study to determine the in vivo dialysance of this drug and found it to average 22 ml per minute. The quantity of the drug removed by four hours of dialysis was approximately 30% of the dose administered intravenously one half hour before dialysis.
N D, Vaziri +4 more
openaire +2 more sources
Reactions Weekly, 2005
Abstract Rationale Chronic mountain sickness or Monge's disease is characterized by an excessive polycythemia in high-altitude dwellers, with a prevalence of 5 to 18% above 3,200 m.
Jean-Paul Richalet +9 more
openaire +2 more sources
Abstract Rationale Chronic mountain sickness or Monge's disease is characterized by an excessive polycythemia in high-altitude dwellers, with a prevalence of 5 to 18% above 3,200 m.
Jean-Paul Richalet +9 more
openaire +2 more sources
Effects of acetazolamide on myotonia
Annals of Neurology, 1978AbstractMyotonia can occur in the periodic paralyses, particularly the hyperkalemic form. The beneficial response to acetazolamide in hypokalemic and hyperkalemic periodic paralysis has led us to study the effect of acetazolamide in 9 patients with disorders having myotonia as the major problem, 7 with myotonia congenita and 2 with paramyotonia ...
R C, Griggs +3 more
openaire +3 more sources
Cardiology in Review, 2011
Acetazolamide is the only carbonic anhydrase inhibitor with significant diuretic effects. It is readily absorbed and undergoes renal elimination by tubular secretion. Its administration is ordinarily marked by a brisk alkaline diuresis. Although carbonic anhydrase inhibitors are proximal tubular diuretics (where the bulk of sodium re-absorption occurs),
Rahim, Kassamali, Domenic A, Sica
openaire +2 more sources
Acetazolamide is the only carbonic anhydrase inhibitor with significant diuretic effects. It is readily absorbed and undergoes renal elimination by tubular secretion. Its administration is ordinarily marked by a brisk alkaline diuresis. Although carbonic anhydrase inhibitors are proximal tubular diuretics (where the bulk of sodium re-absorption occurs),
Rahim, Kassamali, Domenic A, Sica
openaire +2 more sources